Tune in to the replay of Part 2 of our Avalere Market Access Enablement Strategies webinar series to learn about the policy changes and market factors that could impact the future relationships between manufacturers, health plans, and pharmacy benefit managers.

Recent pricing and policy developments may create major shifts in plan design and preparation. Join our policy and market access experts to evaluate forward-leaning considerations and perspectives for how to best prepare for these developments and adapt your business strategies.

• Executive orders related to drug pricing (e.g., rebate rule, importation, international pricing index, 340B)
• State-level regulation and legislation
• CMS’s proposed value-based purchasing rule: possible impact on manufacturers, healthcare plans, and PBMs
• COVID-19 impacts and coverage shifts

This webinar was recorded on September 22, 2020.

In this episode of Avalere Health Essential Voice, experts from our market access and policy teams discuss the different approaches to drug-pricing policies ahead of the 2020 election.

Tune in to the replay of Part 1 of our Avalere Market Access Enablement Strategies webinar series to learn how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.

From value, evidence, and pricing to access, coverage, and reimbursement to insights and commercialization strategy, the COVID-19 pandemic has created new challenges for innovative life sciences companies to bring products to market. Join our experts to learn about the approaches that can be taken in this virtual era to support stakeholder engagement and patient uptake.

Key Topics

• Pre-/post-launch planning
• Third-party channel and distribution
• Patient access strategy
• Customer models and engagement

This webinar was recorded on September 18, 2020.

In this episode of Avalere Health Essential Voice Journal Club Review, our policy experts discuss the findings, themes, and relevant application of a recent study on the degree to which statewide face mask mandates contribute to a reduction in the spread of COVID-19.

In this episode of Start Your Day with Avalere, our Market Access experts continue their discussion on clinical pathways in the context of value in oncology.

In this episode of Avalere Health Essential Voice, experts from Avalere and the Washington State Department of Health continue the discussion on social determinants of health (SDOH), focusing on maternal and child health in the context of public health programs, healthcare access, and health outcomes.

In this episode of Avalere Health Essential Voice, experts from our policy and vaccines teams discuss the differences in healthcare platforms ahead of the 2020 election.

In this episode of Avalere Health Essential Voice Journal Club Review, experts from our Center for Healthcare Transformation discuss the findings, themes, and relevant application of a recent study on the correlation between neighborhood racial and economic polarization, hospital of delivery, and severe maternal morbidity.

In this episode of Start Your Day with Avalere, our experts continue the discussion around challenges within the vaccines marketplace, and the gaps in policy and infrastructure that affect uptake.

In this episode of Start Your Day with Avalere, health IT and policy expert Julie Barnes discusses opportunities for health plans amid interoperability rules and lends insight into the potential requirements that lie ahead.